Navigation Links
NIAID begins clinical trial of West Nile virus vaccine

A small trial testing the safety of an experimental vaccine targeting West Nile virus (WNV) opened today at the National Institutes of Health's (NIH) Clinical Center in Bethesda, MD. The vaccine, which will be tested first in 15 healthy adult volunteers, was developed for human clinical studies by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), and Vical Inc., San Diego, based on an animal vaccine tested at the Centers for Disease Control and Prevention (CDC). Vical also manufactures the experimental vaccine.

"Although the prevalence of West Nile virus disease fluctuates seasonally and regionally, it continues to pose a serious public health threat, especially to older adults and people with weakened immune systems," says Anthony S. Fauci, M.D., director of the NIAID.

WNV, initially isolated in Uganda in 1937, made its first U.S. appearance in New York City in 1999. The virus usually is transmitted to humans through the bite of a mosquito that has been infected after feeding on an infected bird or animal. The virus also can be spread through blood transfusions, organ transplants and breastfeeding, as well as from mother to child during pregnancy. Most people experience no symptoms or only mild symptoms, such as fever, headache and body aches; more serious cases can lead to infections of the brain and nervous system, such as encephalitis or meningitis. In 2004, 2,470 cases of WNV disease were reported in the United States, resulting in 88 deaths. Currently, no WNV vaccine is licensed for use in humans.

The experimental vaccine is composed of a small, circular piece of DNA--called a DNA plasmid--that contains genes that code for two key surface proteins of the West Nile virus. When the vaccine is injected into the muscle, the inner machinery of the muscle cells "reads" the DNA and converts it into two WNV proteins. Recognizing that the proteins are foreign, the muscle cells display
'"/>

Source:NIH


Page: 1 2 3

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
3. NIAID researchers show how promising TB drug works
4. NIAID DNA vaccine for H5N1 avian influenza enters human trial
5. NIAID expands capability for influenza research and surveillance
6. International trial of two microbicides begins
7. Wyoming cloud seeding experiment begins this month
8. Cancer scientists create human leukemia process to map how disease begins, progresses
9. Roche clinical trial registry and results database launched
10. Compound might defeat African sleeping sickness, clinical trial beginning this month
11. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIAID begins clinical trial West Nile virus vaccine

(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... news release is available in German . ... they also infect bacteria. Those protect themselves with a kind of ... in the genetic material of the bacteria and a suitable enzyme. ... it up and thus makes the invaders harmless. Scientists from the ...
... study led by Madhwa Raj, PhD, Research Professor in Obstetrics ... its Stanley S. Scott Cancer Center, has found that a ... and plant roots killed 100% of sample breast cancer cells ... also revealed potential treatment target genes, are published in the ...
... The University of California, Riverside announced today that ... funded by the Bill & Melinda Gates Foundation. Yanping ... research project, titled "Using Sensors to Understand Insect-Vectored Diseases ... funds individuals worldwide to explore ideas that can break ...
Cached Biology News:Powerful tool for genetic engineering 2Powerful tool for genetic engineering 3LSUHSC research finds combo of plant nutrients kills breast cancer cells 2Using data to fight malaria 2
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the company is making good progress in evaluating the full range of capabilities ... stem cells. Adult tissue stem cells perform the day-to-day renewal and repair of ...
(Date:7/28/2015)... Ashland, Virginia (PRWEB) , ... July 29, 2015 , ... The new Xsample 530 ... refractometer. It handles a wide range of liquid viscosities – from less than 12,000 mPas ... in 12 mL vials. , What immediately catches the eye about Xsample 530 is ...
(Date:7/28/2015)... ... July 28, 2015 , ... In terms ... in 2013; while production volume reached close to 1.84 million tonnes in the ... share of 75.5% of the region’s total aluminium hydroxide production; the country’s aluminium ...
(Date:7/28/2015)... 2015 Deerfield Management Company, L.P. today announced ... which will invest in groundbreaking advancements in science that ... and orphan diseases. The venture capital fund will also ... developed and improve the way healthcare is delivered to ... healthcare-focused venture funds in the sector, will donate all ...
Breaking Biology Technology:Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4New Moves in Automatic Sample Handling: Introducing Xsample 530 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
... Event ... ... Oct. 3 ThirdBiotech Inc., http://www.thirdbiotech.com, a biotechnology incubator and life ... to be held on Thursday, October 23rd, 2008,between noon and 5pm at ...
... Two leading companies,in their respective industries are ... cell harvesting process., SpineSmith Partners LP, an ... an exclusive national and global distribution agreement,with WAVE(R) ... two companies grants SpineSmith the exclusive rights to ...
... Oct. 3 ( http://www.amdl.com ),AMDL, Inc. (Amex: ... operations in China and the US, today announced that ... Conference in New,York City on Tuesday, October 7, 2008 ... the Grand Hyatt New York Hotel in the Morosco ...
Cached Biology Technology:First Annual Arizona Biotech Day Announced for October 23rd 2008 2First Annual Arizona Biotech Day Announced for October 23rd 2008 3New Partnership Integrates Vibration Therapy Into Stem Cell Procedures 2New Partnership Integrates Vibration Therapy Into Stem Cell Procedures 3AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 3
... shaker flask clips, purpose-designed to firmly retain ... clips are equipped with a top retainer ... a bottom retainer spring, and silicon tubing ... glassware. Clips include the required mounting ...
... flask clips, purpose-designed to firmly retain glassware, ... are equipped with a top retainer spring; ... bottom retainer spring, and silicon tubing spring ... Clips include the required mounting screws., ...
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
... duty stainless-steel shaker flask clips, purpose-designed to ... All clips are equipped with a ... also include a bottom retainer spring, and ... of expensive glassware. Clips include the ...
Biology Products: